医学分子生物学杂志 ›› 2023, Vol. 20 ›› Issue (5): 382-389.doi: 10.3870/j.issn.1672-8009.2023.05.002

• 论著 • 上一篇    下一篇

PD-1 抑制剂通过 STAT6 介导肿瘤相关巨噬细胞极化抑制前列腺癌细胞的增殖和侵袭

  

  1. 海南省肿瘤医院泌尿外科 海口市, 570311
  • 出版日期:2023-09-30 发布日期:2023-11-13
  • 基金资助:
    海南省自然科学基金(No. 822RC851)

PD-1 Inhibitor Inhibits Prostate Cancer Cell Proliferation and Invasion through STAT6 Mediated Tumor-associated Macrophage Polarization

  1. Department of Urology, Hainan Cancer Hospital, Haikou, 570311, China
  • Online:2023-09-30 Published:2023-11-13

摘要: 目的 探究 PD-1 抑制剂对肿瘤相关巨噬细胞 ( tumor-associated macrophages, TAM) 极化和前列 腺癌细胞增殖和侵袭的作用及其相关机制。 方法 采集 25 例前列腺癌患者肿瘤及癌旁组织, 实时定量荧光 PCR (qRT-PCR) 检测程序性死亡因子 1 (programmed death-1, PD-1)、 巨噬细胞甘露糖受体 (macrophage mannose receptor, CD206) 和信号转导和转录激活因子 6 ( signal transduction and transcription activator 6, STAT6) 表达水平并进行斯皮尔曼 ( Spearman) 相关性分析。 将人单核细胞白血病细胞 ( human monocytic leukemia cells, THP-1) 细胞诱导为 TAM, 期间加入 PD-1 抑制剂 Camrelizumab, 分组为 M0 组、 M0 + Camrelizumab 组、 TAM 组、 TAM + Camrelizumab 组; THP-1 细胞诱导为 TAM 期间加入 STAT6 抑制剂 AS1517499, 分组为 M0 组、 M0 + AS1517499 组、 TAM 组、 TAM + AS1517499 组。 通过 qRT-PCR 和蛋白质印迹法检测 STAT6 和 CD206 表达水平, 酶联免疫吸附反应检测白介素 13 ( interleukin-13, IL-13)、 转化生长因子-β (transforming growth factor-β, TGF-β) 和一氧化氮合成酶 ( nitric oxide synthase, iNOS) 分泌水平。 将各组 细胞分别与前列腺癌细胞 DU145 共孵育, 通过 CCK8 检测 DU145 细胞增殖水平, Transwell 检测 DU145 细胞 侵袭水平。 结果 与癌旁组织相比, 前列腺肿瘤组织中 PD-1、 CD206 和 STAT6 表达水平升高, 并在肿瘤组 织中呈正相关 (P均 < 0. 05)。 与 M0 组相比, TAM 组 CD206 和 STAT6 表达水平升高, IL-13、 TGF-β 分泌水 平增加, iNOS 分泌水平减少, 与其共孵育的 DU145 细胞增殖水平升高, 侵袭能力增强 (P均 < 0. 05)。 与 TAM 组相比, TAM + Camrelizumab 组 CD206 和 STAT6 表达水平降低, IL-13、 TGF-β 分泌水平减少, iNOS 分泌水平增加, 与其共孵育的 DU145 细胞增殖水平降低, 侵袭能力减弱 (P均 < 0. 05)。 与 TAM 组相比, TAM + AS1517499 组 CD206 表达水平降低, IL-13、 TGF-β 分泌水平减少, iNOS 分泌水平增加, 与其共孵育 的 DU145 细胞增殖水平降低, 侵袭能力减弱 (P均 < 0. 05)。 结论 PD-1 抑制剂通过抑制巨噬细胞向 TAM 极化从而降低前列腺癌细胞的增殖和侵袭, 其作用机制可能是通过抑制巨噬细胞 STAT6 通路实现。 

关键词: 肿瘤相关巨噬细胞, 巨噬细胞极化, 前列腺癌, PD-1 抑制剂 

Abstract: Objective To investigate the effect of PD-1 inhibitors on tumor-associated macrophage (TAM) polarization and proliferation and invasion of prostate cancer, and the related mechanisms. Methods The tumor and adjacent tissues of 25 patients with prostate cancer were collected. The expression levels of programmed death factor 1 ( PD-1), macrophage mannose receptor (CD206) and signal transduction and transcription activator 6 ( STAT6) were detected by realtime quantitative fluorescent PCR ( qRT-PCR), and Spearman correlation analysis was then performed. Human monocytic leukemia cells (THP-1) were induced to TAM, during which the PD-1 inhibitor Camrelizumab or the STAT6 inhibitor AS1517499 was added. The above cells were divided into 4 groups of M0, M0 + Camrelizumab, TAM and TAM + Camrelizumab, or 4 groups of M0, M0 + AS1517499, TAM and TAM + AS1517499. The expression levels of STAT6 and CD206 were detected by qRT-PCR and Western blotting, and the concentration of interleukin-13 ( IL-13 ), transforming growth factor-β ( TGF-β) and nitric oxide synthase ( iNOS) were detected by enzyme-linked immunosorbent assay ( ELISA). Each group of cells were co-cultured with prostate cancer cells (DU145). The proliferation level of DU145 cells were detected by CCK8, and the invasion level were detected by Transwell assay. Results The expression levels of PD-1, CD206 and STAT6 in the prostate tumor tissues were elevated when compared with those in the adjacent tissues, and the expressions of PD-1, STAT6 were positively correlated with the expression of CD206 in tumor tissues respectively (all P< 0. 05). The expression levels of CD206 and STAT6 and the secretion levels of IL-13 and TGF-β were increased, while the level of iNOS was decreased in the TAM group, when compared with those in the M0 group, and the proliferation and invasion ability of DU145 cells co-cultured with the TAM were increased ( all P < 0. 05). The expression levels of CD206 and STAT6 were reduced in the TAM + Camrelizumab group when compared with the TAM group, in addition, the secretion levels of IL-13 and TGF-β were also decreased, the secretion levels of iNOS was increased. Meanwhile, the proliferation and invasion ability of DU145 cells cocultured with cells in the TAM + Camrelizumab group were decreased (all P < 0. 05). The cells in the TAM + AS1517499 group also had the reduced expression level of CD206, decreased secretion levels of IL-13 and TGF-β and increased secretion levels of iNOS when compared with those in the TAM group. Meanwhile, the proliferation and invasion ability of DU145 cells co-cultured with cells in the TAM + AS1517499 group were decreased (all P < 0. 05). Conclusion PD-1 inhibitors reduce the proliferation and invasion of prostate cancer cells by inhibiting the polarization of macrophages to TAM, which may be achieved by inhibiting the STAT6 signaling pathway in macrophages

Key words: tumor-associated macrophages, macrophage polarization, prostate cancer, programmed death-1 inhibitors

中图分类号: